Skip to main content
NCBI home page
Gut logoLink to Gut
. 1997 Mar;40(3):291–293. doi: 10.1136/gut.40.3.291

Clinical relevance of hepatitis C virus genotypes.

P Simmonds 1
PMCID: PMC1027074  PMID: 9135513

Full text

PDF
291

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Booth J. C., Foster G. R., Kumar U., Galassini R., Goldin R. D., Brown J. L., Thomas H. C. Chronic hepatitis C virus infections: predictive value of genotype and level of viraemia on disease progression and response to interferon alpha. Gut. 1995 Mar;36(3):427–432. doi: 10.1136/gut.36.3.427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Braconier J. H., Paulsen O., Engman K., Widell A. Combined alpha-interferon and ribavirin treatment in chronic hepatitis C: a pilot study. Scand J Infect Dis. 1995;27(4):325–329. doi: 10.3109/00365549509032725. [DOI] [PubMed] [Google Scholar]
  3. Bukh J., Miller R. H., Purcell R. H. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis. 1995 Feb;15(1):41–63. doi: 10.1055/s-2007-1007262. [DOI] [PubMed] [Google Scholar]
  4. Chemello L., Bonetti P., Cavalletto L., Talato F., Donadon V., Casarin P., Belussi F., Frezza M., Noventa F., Pontisso P. Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C. The TriVeneto Viral Hepatitis Group. Hepatology. 1995 Sep;22(3):700–706. doi: 10.1002/hep.1840220303. [DOI] [PubMed] [Google Scholar]
  5. Chemello L., Cavalletto L., Bernardinello E., Guido M., Pontisso P., Alberti A. The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C. J Hepatol. 1995;23 (Suppl 2):8–12. [PubMed] [Google Scholar]
  6. Chen C. H., Sheu J. C., Wang J. T., Huang G. T., Yang P. M., Lee H. S., Lee C. Z., Chen D. S. Genotypes of hepatitis C virus in chronic liver disease in Taiwan. J Med Virol. 1994 Nov;44(3):234–236. doi: 10.1002/jmv.1890440304. [DOI] [PubMed] [Google Scholar]
  7. Choo Q. L., Kuo G., Ralston R., Weiner A., Chien D., Van Nest G., Han J., Berger K., Thudium K., Kuo C. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1294–1298. doi: 10.1073/pnas.91.4.1294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Choo Q. L., Kuo G., Weiner A. J., Overby L. R., Bradley D. W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989 Apr 21;244(4902):359–362. doi: 10.1126/science.2523562. [DOI] [PubMed] [Google Scholar]
  9. Dhaliwal S. K., Prescott L. E., Dow B. C., Davidson F., Brown H., Yap P. L., Follett E. A., Simmonds P. Influence of viraemia and genotype upon serological reactivity in screening assays for antibody to hepatitis C virus. J Med Virol. 1996 Feb;48(2):184–190. doi: 10.1002/(SICI)1096-9071(199602)48:2<184::AID-JMV11>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]
  10. Dusheiko G., Schmilovitz-Weiss H., Brown D., McOmish F., Yap P. L., Sherlock S., McIntyre N., Simmonds P. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology. 1994 Jan;19(1):13–18. [PubMed] [Google Scholar]
  11. Enomoto N., Sakuma I., Asahina Y., Kurosaki M., Murakami T., Yamamoto C., Izumi N., Marumo F., Sato C. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J Clin Invest. 1995 Jul;96(1):224–230. doi: 10.1172/JCI118025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Enomoto N., Sakuma I., Asahina Y., Kurosaki M., Murakami T., Yamamoto C., Ogura Y., Izumi N., Marumo F., Sato C. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med. 1996 Jan 11;334(2):77–81. doi: 10.1056/NEJM199601113340203. [DOI] [PubMed] [Google Scholar]
  13. Féray C., Gigou M., Samuel D., Paradis V., Mishiro S., Maertens G., Reynés M., Okamoto H., Bismuth H., Bréchot C. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology. 1995 Apr;108(4):1088–1096. doi: 10.1016/0016-5085(95)90207-4. [DOI] [PubMed] [Google Scholar]
  14. Gane E. J., Naoumov N. V., Qian K. P., Mondelli M. U., Maertens G., Portmann B. C., Lau J. Y., Williams R. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology. 1996 Jan;110(1):167–177. doi: 10.1053/gast.1996.v110.pm8536853. [DOI] [PubMed] [Google Scholar]
  15. Gane E. J., Portmann B. C., Naoumov N. V., Smith H. M., Underhill J. A., Donaldson P. T., Maertens G., Williams R. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med. 1996 Mar 28;334(13):815–820. doi: 10.1056/NEJM199603283341302. [DOI] [PubMed] [Google Scholar]
  16. Hawkins A., Davidson F., Simmonds P. Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution method. J Clin Microbiol. 1997 Jan;35(1):187–192. doi: 10.1128/jcm.35.1.187-192.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Haydon G. H., Jarvis L. M., Simmonds P., Hayes P. C. Association between chronic hepatitis C infection and hepatocellular carcinoma. Lancet. 1995 Apr 8;345(8954):928–929. doi: 10.1016/s0140-6736(95)90045-4. [DOI] [PubMed] [Google Scholar]
  18. Horiike N., Masumoto T., Nakanishi K., Michitaka K., Kurose K., Ohkura I., Onji M. Interferon therapy for patients more than 60 years of age with chronic hepatitis C. J Gastroenterol Hepatol. 1995 May-Jun;10(3):246–249. doi: 10.1111/j.1440-1746.1995.tb01088.x. [DOI] [PubMed] [Google Scholar]
  19. Idéo G., Bellobuono A., Mondazzi L., Tempini S., Bellati G., Idéo G. M., Silini E. Alpha interferon treatment in chronic hepatitis C. Clin Exp Rheumatol. 1995 Nov-Dec;13 (Suppl 13):S167–S173. [PubMed] [Google Scholar]
  20. Kasahara A., Hayashi N., Hiramatsu N., Oshita M., Hagiwara H., Katayama K., Kato M., Masuzawa M., Yoshihara H., Kishida Y. Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: a multicenter randomized controlled trial. Hepatology. 1995 Feb;21(2):291–297. [PubMed] [Google Scholar]
  21. Kobayashi M., Tanaka E., Sodeyama T., Urushihara A., Matsumoto A., Kiyosawa K. The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatology. 1996 Apr;23(4):695–699. doi: 10.1053/jhep.1996.v23.pm0008666319. [DOI] [PubMed] [Google Scholar]
  22. Koff R. S., Seeff L. B. Economic modeling of treatment in chronic hepatitis B and chronic hepatitis C: promises and limitations. Hepatology. 1995 Dec;22(6):1880–1882. [PubMed] [Google Scholar]
  23. Kuo G., Choo Q. L., Alter H. J., Gitnick G. L., Redeker A. G., Purcell R. H., Miyamura T., Dienstag J. L., Alter M. J., Stevens C. E. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989 Apr 21;244(4902):362–364. doi: 10.1126/science.2496467. [DOI] [PubMed] [Google Scholar]
  24. Lau J. Y., Davis G. L., Prescott L. E., Maertens G., Lindsay K. L., Qian K., Mizokami M., Simmonds P. Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group. Ann Intern Med. 1996 May 15;124(10):868–876. doi: 10.7326/0003-4819-124-10-199605150-00002. [DOI] [PubMed] [Google Scholar]
  25. Lau J. Y., Simmonds P., Urdea M. S. Implications of variations of "conserved" regions of hepatitis C virus genome. Lancet. 1995 Aug 12;346(8972):425–426. doi: 10.1016/s0140-6736(95)92786-7. [DOI] [PubMed] [Google Scholar]
  26. Lee D. S., Sung Y. C., Whang Y. S. Distribution of HCV genotypes among blood donors, patients with chronic liver disease, hepatocellular carcinoma, and patients on maintenance hemodialysis in Korea. J Med Virol. 1996 May;49(1):55–60. doi: 10.1002/(SICI)1096-9071(199605)49:1<55::AID-JMV9>3.0.CO;2-J. [DOI] [PubMed] [Google Scholar]
  27. McOmish F., Chan S. W., Dow B. C., Gillon J., Frame W. D., Crawford R. J., Yap P. L., Follett E. A., Simmonds P. Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion. 1993 Jan;33(1):7–13. doi: 10.1046/j.1537-2995.1993.33193142314.x. [DOI] [PubMed] [Google Scholar]
  28. Mita E., Hayashi N., Kanazawa Y., Hagiwara H., Ueda K., Kasahara A., Fusamoto H., Kamada T. Hepatitis C virus genotype and RNA titer in the progression of type C chronic liver disease. J Hepatol. 1994 Sep;21(3):468–473. doi: 10.1016/s0168-8278(05)80330-7. [DOI] [PubMed] [Google Scholar]
  29. Pawlotsky J. M., Roudot-Thoraval F., Pellet C., Aumont P., Darthuy F., Remire J., Duval J., Dhumeaux D. Influence of hepatitis C virus (HCV) genotypes on HCV recombinant immunoblot assay patterns. J Clin Microbiol. 1995 May;33(5):1357–1359. doi: 10.1128/jcm.33.5.1357-1359.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Pawlotsky J. M., Tsakiris L., Roudot-Thoraval F., Pellet C., Stuyver L., Duval J., Dhumeaux D. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis. 1995 Jun;171(6):1607–1610. doi: 10.1093/infdis/171.6.1607. [DOI] [PubMed] [Google Scholar]
  31. Prati D., Capelli C., Zanella A., Mozzi F., Bosoni P., Pappalettera M., Zanuso F., Vianello L., Locatelli E., de Fazio C. Influence of different hepatitis C virus genotypes on the course of asymptomatic hepatitis C virus infection. Gastroenterology. 1996 Jan;110(1):178–183. doi: 10.1053/gast.1996.v110.pm8536854. [DOI] [PubMed] [Google Scholar]
  32. Seeff L. B., Buskell-Bales Z., Wright E. C., Durako S. J., Alter H. J., Iber F. L., Hollinger F. B., Gitnick G., Knodell R. G., Perrillo R. P. Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group. N Engl J Med. 1992 Dec 31;327(27):1906–1911. doi: 10.1056/NEJM199212313272703. [DOI] [PubMed] [Google Scholar]
  33. Simmonds P., Mellor J., Craxi A., Sanchez-Tapias J. M., Alberti A., Prieto J., Colombo M., Rumi M. G., Lo Iacano O., Ampurdanes-Mingall S. Epidemiological, clinical and therapeutic associations of hepatitis C types in western European patients. J Hepatol. 1996 May;24(5):517–524. doi: 10.1016/s0168-8278(96)80135-8. [DOI] [PubMed] [Google Scholar]
  34. Simmonds P. Variability of hepatitis C virus. Hepatology. 1995 Feb;21(2):570–583. doi: 10.1002/hep.1840210243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Smith D. B., Davidson F., Yap P., Brown H., Kolberg J., Detmer J., Urdea M., Simmonds P., International HCV Collaborati Levels of hepatitis C virus in blood donors infected with different viral genotypes. International HCV Collaborative Study Group. J Infect Dis. 1996 Mar;173(3):727–730. doi: 10.1093/infdis/173.3.727. [DOI] [PubMed] [Google Scholar]
  36. Smith D. B., Pathirana S., Davidson F., Lawlor E., Power J., Yap P. L., Simmonds P. The origin of hepatitis C virus genotypes. J Gen Virol. 1997 Feb;78(Pt 2):321–328. doi: 10.1099/0022-1317-78-2-321. [DOI] [PubMed] [Google Scholar]
  37. Stuyver L., Wyseur A., van Arnhem W., Lunel F., Laurent-Puig P., Pawlotsky J. M., Kleter B., Bassit L., Nkengasong J., van Doorn L. J. Hepatitis C virus genotyping by means of 5'-UR/core line probe assays and molecular analysis of untypeable samples. Virus Res. 1995 Oct;38(2-3):137–157. doi: 10.1016/0168-1702(95)00052-r. [DOI] [PubMed] [Google Scholar]
  38. Takada A., Tsutsumi M., Zhang S. C., Okanoue T., Matsushima T., Fujiyama S., Komatsu M. Relationship between hepatocellular carcinoma and subtypes of hepatitis C virus: a nationwide analysis. J Gastroenterol Hepatol. 1996 Feb;11(2):166–169. doi: 10.1111/j.1440-1746.1996.tb00055.x. [DOI] [PubMed] [Google Scholar]
  39. Takada N., Takase S., Enomoto N., Takada A., Date T. Clinical backgrounds of the patients having different types of hepatitis C virus genomes. J Hepatol. 1992 Jan;14(1):35–40. doi: 10.1016/0168-8278(92)90128-c. [DOI] [PubMed] [Google Scholar]
  40. Tanaka K., Ikematsu H., Hirohata T., Kashiwagi S. Hepatitis C virus infection and risk of hepatocellular carcinoma among Japanese: possible role of type 1b (II) infection. J Natl Cancer Inst. 1996 Jun 5;88(11):742–746. doi: 10.1093/jnci/88.11.742. [DOI] [PubMed] [Google Scholar]
  41. Tokita H., Okamoto H., Iizuka H., Kishimoto J., Tsuda F., Lesmana L. A., Miyakawa Y., Mayumi M. Hepatitis C virus variants from Jakarta, Indonesia classifiable into novel genotypes in the second (2e and 2f), tenth (10a) and eleventh (11a) genetic groups. J Gen Virol. 1996 Feb;77(Pt 2):293–301. doi: 10.1099/0022-1317-77-2-293. [DOI] [PubMed] [Google Scholar]
  42. Tsuji H., Shimomura H., Wato M., Kondo J., Tsuji T. Virological and serological characterization of asymptomatic blood donors positive for anti-hepatitis C virus antibody. Acta Med Okayama. 1995 Jun;49(3):137–144. doi: 10.18926/AMO/30409. [DOI] [PubMed] [Google Scholar]
  43. Watson J. P., Brind A. M., Chapman C. E., Bates C. L., Gould F. K., Johnson S. J., Burt A. D., Ferguson J., Simmonds P., Bassendine M. F. Hepatitis C virus: epidemiology and genotypes in the north east of England. Gut. 1996 Feb;38(2):269–276. doi: 10.1136/gut.38.2.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Yamada M., Kakumu S., Yoshioka K., Higashi Y., Tanaka K., Ishikawa T., Takayanagi M. Hepatitis C virus genotypes are not responsible for development of serious liver disease. Dig Dis Sci. 1994 Feb;39(2):234–239. doi: 10.1007/BF02090191. [DOI] [PubMed] [Google Scholar]
  45. Yotsuyanagi H., Koike K., Yasuda K., Moriya K., Hino K., Kurokawa K., Iino S. Hepatitis C virus genotypes and development of hepatocellular carcinoma. Cancer. 1995 Oct 15;76(8):1352–1355. doi: 10.1002/1097-0142(19951015)76:8<1352::aid-cncr2820760809>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  46. Zignego A. L., Ferri C., Giannini C., Monti M., La Civita L., Careccia G., Longombardo G., Lombardini F., Bombardieri S., Gentilini P. Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med. 1996 Jan 1;124(1 Pt 1):31–34. doi: 10.7326/0003-4819-124-1_Part_1-199601010-00006. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES